NovaPoint Capital’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
67,081
+1,966
+3% +$283K 2.46% 10
2026
Q1
$8.23M Buy
65,115
+1,188
+2% +$167K 2.06% 14
2025
Q4
$8.64M Buy
63,927
+1,734
+3% +$232K 2.22% 14
2025
Q3
$7.7M Buy
62,193
+2,570
+4% +$282K 1.88% 15
2025
Q2
$5.89M Buy
59,623
+3,236
+6% +$265K 1.8% 18
2025
Q1
$3.7M Buy
+56,387
New +$3.85M 1.14% 34
2024
Q4
Sell
-49,371
Closed -$3.22M 129
2024
Q3
$3.22M Buy
49,371
+2,855
+6% +$185K 1% 42
2024
Q2
$3.13M Buy
46,516
+6,786
+17% +$428K 1.06% 40
2024
Q1
$2.29M Buy
+39,730
New +$2.08M 0.8% 47

Other funds holding APH

NovaPoint Capital's APH Position: Q2 2026 in Review

NovaPoint Capital increased its Amphenol (APH) stake by 3% in Q2 2026, buying an estimated $283K and bringing the position to 67,081 shares worth $11.8M. The position accounts for 2.46% of the portfolio, ranked #10.

NovaPoint Capital first reported a position in APH in Q1 2024 and has held it in 9 quarters since. 2,323 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • NovaPoint Capital held 67,081 shares of Amphenol worth $11.8M as of Q2 2026.
  • NovaPoint Capital bought 1,966 Amphenol shares in Q2 2026, an estimated $283K.
  • Amphenol made up 2.46% of NovaPoint Capital's portfolio in Q2 2026, its #10 holding.
  • NovaPoint Capital first reported a position in Amphenol in Q1 2024 and has held it in 9 quarters since.
  • 2,323 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.